
CAMBRIDGE COGNITION HOLDINGS PLC — Investor Relations & Filings
Cambridge Cognition Holdings PLC is a neuroscience technology company that develops and markets digital solutions to assess brain health. The company provides an end-to-end platform for Central Nervous System (CNS) clinical trials, featuring a suite of scientifically validated digital cognitive assessments. Its technologies include touchscreen tests, voice analysis, electronic questionnaires, and high-frequency testing, which can be deployed both in-clinic and remotely for decentralized trials. These tools are utilized by pharmaceutical companies, academic research institutions, and healthcare professionals to accelerate drug development and enhance the understanding and treatment of conditions affecting brain health. With over 30 years of scientific validation, its assessments are recognized for their sensitivity in detecting subtle cognitive changes across numerous therapeutic areas.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| COG to present at Mello 2026 | 2026-06-01 | English | |
| Launch of brain health study with Oura | 2026-05-28 | English | |
| Result of AGM | 2026-05-21 | English | |
| Posting of Annual Report & Notice of AGM | 2026-04-24 | English | |
| Results for the year ended 31 December 2025 | 2026-04-13 | English | |
| Notice of Results | 2026-04-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 47911677 | COG to present at Mello 2026 | 2026-06-01 | English | ||
| 47860157 | Launch of brain health study with Oura | 2026-05-28 | English | ||
| 46738379 | Result of AGM | 2026-05-21 | English | ||
| 36153978 | Posting of Annual Report & Notice of AGM | 2026-04-24 | English | ||
| 34392172 | Results for the year ended 31 December 2025 | 2026-04-13 | English | ||
| 33685094 | Notice of Results | 2026-04-07 | English | ||
| 33684830 | Appointment of Nominated Adviser and Joint Broker | 2026-04-07 | English | ||
| 33128450 | Block Listing Return | 2026-04-01 | English | ||
| 32927387 | Monument Therapeutics MT1988 First Patient Dosed | 2026-03-11 | English | ||
| 34560961 | Commercialisation Agreement | 2026-02-16 | English | ||
| 18023140 | Change of Joint Broker | 2026-02-09 | English | ||
| 13006385 | Trading Update | 2026-01-19 | English | ||
|
2025
3 filings
| |||||
| 8101361 | Change of Auditor | 2025-11-05 | English | ||
| 8101321 | Board Updates | 2025-11-05 | English | ||
| 7943749 | Block Listing Return | 2025-10-01 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for CAMBRIDGE COGNITION HOLDINGS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
|
Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietar…
|
196170 | KR | Professional, scientific and te… |
|
ALTERITY THERAPEUTICS LIMITED
Clinical-stage developer of disease-modifying therapies for…
|
ATH | AU | Professional, scientific and te… |
|
AlzeCure Pharma
Develops therapies for severe diseases, focusing on Alzheim…
|
ALZCUR | SE | Professional, scientific and te… |
|
AMPLIA THERAPEUTICS LIMITED
Clinical-stage developer of FAK inhibitors for solid tumors…
|
ATX | AU | Professional, scientific and te… |
|
ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapeutics f…
|
ANAB | US | Professional, scientific and te… |
|
ANATARA LIFESCIENCES LTD
Develops non-antibiotic gastrointestinal health solutions f…
|
ANR | AU | Professional, scientific and te… |
|
AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and he…
|
251280 | KR | Professional, scientific and te… |
|
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
Pharmaceutical CRO specializing in clinical trials, BE stud…
|
301520 | CN | Professional, scientific and te… |
|
Anixa Biosciences Inc
A clinical-stage biotech developing therapies and vaccines …
|
ANIX | US | Professional, scientific and te… |
CAMBRIDGE COGNITION HOLDINGS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7543/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7543 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7543 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7543 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7543}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CAMBRIDGE COGNITION HOLDINGS PLC (id: 7543)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.